triflusal has been researched along with n-methylaspartate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acarin, L; Castellano, B; González, B | 2 |
2 other study(ies) available for triflusal and n-methylaspartate
Article | Year |
---|---|
Triflusal posttreatment inhibits glial nuclear factor-kappaB, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain.
Topics: Administration, Oral; Animals; Astrocytes; Brain; DNA-Binding Proteins; Down-Regulation; Drug Administration Schedule; Glial Fibrillary Acidic Protein; Microglia; Microinjections; N-Methylaspartate; Neuroglia; Neuroprotective Agents; NF-kappa B; Platelet Aggregation Inhibitors; Rats; Rats, Long-Evans; Salicylates; STAT3 Transcription Factor; Trans-Activators | 2001 |
Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal excitotoxic damage.
Topics: Administration, Oral; Animals; Astrocytes; Cyclooxygenase 2; Disease Models, Animal; Inflammation Mediators; Interleukin-1; Isoenzymes; Microglia; Microinjections; N-Methylaspartate; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Neurotoxins; Neutrophil Infiltration; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Long-Evans; Salicylates; Somatosensory Cortex; Tumor Necrosis Factor-alpha | 2002 |